{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:17:03Z","timestamp":1776334623060,"version":"3.51.2"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T00:00:00Z","timestamp":1633305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3H0011, CMRPG3H0012, CMRPG3H0013"],"award-info":[{"award-number":["CMRPG3H0011, CMRPG3H0012, CMRPG3H0013"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2320-B-182A-012"],"award-info":[{"award-number":["109-2320-B-182A-012"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>To avoid graft rejection, the hematopoietic stem cells with matched classical human leukocyte antigen (HLA) alleles are the primary choice for clinical allogeneic transplantation. However, even if the fully HLA-matched hematopoietic stem cells are used for transplantation, some patients still have poor prognosis after hematopoietic stem cell transplantation (HSCT), suggesting that the HLA system was not the only determinant of the outcomes of HSCT. In this study, we investigated whether the single-nucleotide polymorphisms (SNPs) of the co-stimulatory genes within non-HLA regions were related to the outcomes of HSCT. The genomic DNAs of 163 patients who had acute leukemia and received HSCT and their respective donors were collected for analysis. Thirty-four SNPs located in the four co-stimulatory genes including cytotoxic T-lymphocyte associated protein 4 (CTLA4), CD28, tumor necrosis factor ligand superfamily 4 (TNFSF4), and programmed cell death protein 1 (PDCD1) were selected to explore their relationship with the adverse outcomes after transplantation, including mortality, cytomegalovirus infection, graft-versus-host disease, and relapse. Our results revealed that nine SNPs in the CTLA4 gene, five SNPs in the PDCD1 gene, two SNPs in the TNFSF4 gene, and four SNPs in the CD28 gene were significantly associated with the occurrence of adverse outcomes post-HSCT. These SNPs may play important roles in immune response to allografts post-HSCT and can be the targets for developing strategy to identify appropriate donors.<\/jats:p>","DOI":"10.3389\/fimmu.2021.730507","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T05:05:15Z","timestamp":1633323915000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["The Association Between Single-Nucleotide Polymorphisms of Co-Stimulatory Genes Within Non-HLA Region and the Prognosis of Leukemia Patients With Hematopoietic Stem Cell Transplantation"],"prefix":"10.3389","volume":"12","author":[{"given":"Ding-Ping","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Tzu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-Ping","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Ping","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic Stem-Cell Transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.1983.tb00998.x","article-title":"Gene Order and Gene Distances in the HLA Region Studied by the Haplotype Method","volume":"47","author":"Olaisen","year":"1983","journal-title":"Ann Hum Genet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2013.07.002","article-title":"Interplay Between Immune Responses to HLA and Non-HLA Self-Antigens in Allograft Rejection","volume":"74","author":"Angaswamy","year":"2013","journal-title":"Hum Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.blre.2012.10.001","article-title":"Genetics of Graft-Versus-Host Disease: The Major Histocompatibility Complex","volume":"27","author":"Petersdorf","year":"2013","journal-title":"Blood Rev"},{"key":"B5","article-title":"How Important is Histocompatibility in Bone Marrow Transplantation","volume":"4","author":"Kaminski","year":"1989","journal-title":"Bone Marrow Transplant"},{"key":"B6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3349\/ymj.2007.48.1.11","article-title":"The HLA System: Genetics, Immunology, Clinical Testing, and Clinical Implications","volume":"48","author":"Choo","year":"2007","journal-title":"Yonsei Med J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.03.024","article-title":"HLA-Allele Matched Unrelated Donors Compared to HLA-Matched Sibling Donors: Role of Cell Source and Disease Risk Category","volume":"16","author":"Woolfrey","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.06.016","article-title":"Sibling Versus Unrelated Donor Allogeneic Hematopoietic Cell Transplantation for Chronic Myelogenous Leukemia: Refined HLA Matching Reveals More Graft-Versus-Host Disease But Not Less Relapse","volume":"15","author":"Weisdorf","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI61019","article-title":"Antigen-Presenting Cell-Derived Complement Modulates Graft-Versus-Host Disease","volume":"122","author":"Kwan","year":"2012","journal-title":"J Clin Invest"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2017.05.001","article-title":"Emerging Concepts in Cytomegalovirus Infection Following Hematopoietic Stem Cell Transplantation","volume":"10","author":"Camargo","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2011.00626.x","article-title":"Tetramer Monitoring to Assess Risk Factors for Recurrent Cytomegalovirus Reactivation and Reconstitution of Antiviral Immunity Post Allogeneic Hematopoietic Stem Cell Transplantation","volume":"13","author":"Borchers","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.6.1971","article-title":"Allogeneic Bone Marrow Transplantation for Chronic Myelogenous Leukemia: Comparative Analysis of Unrelated Versus Matched Sibling Donor Transplantation","volume":"99","author":"Weisdorf","year":"2002","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.0952","article-title":"Allogeneic Marrow Stem-Cell Transplantation From Human Leukocyte Antigen-Identical Siblings Versus Human Leukocyte Antigen-Allelic-Matched Unrelated Donors (10\/10) in Patients With Standard-Risk Hematologic Malignancy: A Prospective Study From the French Society of Bone Marrow Transplantation and Cell Therapy","volume":"24","author":"Yakoub-Agha","year":"2006","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182985504","article-title":"Anti-Donor HLA Class I Antibodies: Pathways to Endothelial Cell Activation and Cell-Mediated Allograft Rejection","volume":"96","author":"Naemi","year":"2013","journal-title":"Transplantation"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-355982","article-title":"The Major Histocompatibility Complex: A Model for Understanding Graft-Versus-Host Disease","volume":"122","author":"Petersdorf","year":"2013","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705587","article-title":"Involvement of OX40 Ligand+ Mast Cells in Chronic GVHD After Allogeneic Hematopoietic Stem Cell Transplantation","volume":"39","author":"Kotani","year":"2007","journal-title":"Bone Marrow Transpl"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.8.2963","article-title":"Role of CD28 in Acute Graft-Versus-Host Disease","volume":"92","author":"Yu","year":"1998","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2020","article-title":"Association of Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Single Nucleotide Polymorphism in Donors With Clinical Outcome After Allogeneic Hematopoietic Stem Cell Transplantation: A Meta-Analysis","volume":"26","author":"Wang","year":"2021","journal-title":"Hematology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3390\/jcm8020236","article-title":"Targeting Immune Signaling Checkpoints in Acute Myeloid Leukemia","volume":"8","author":"Giannopoulos","year":"2019","journal-title":"J Clin Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acr.2019.03.003","article-title":"Co-Stimulatory and Co-Inhibitory Pathways in Cancer Immunotherapy","volume":"143","author":"O\u2019Neill","year":"2019","journal-title":"Adv Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000180","article-title":"Immune Checkpoint Inhibitors in Organ Transplant Patients","volume":"40","author":"Kittai","year":"2017","journal-title":"J Immunother"},{"key":"B22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bbmt.2015.08.037","article-title":"Analysis of a Genetic Polymorphism in the Costimulatory Molecule TNFSF4 With Hematopoietic Stem Cell Transplant Outcomes","volume":"22","author":"Jindra","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601135","article-title":"Costimulation Blockade in Autoimmunity and Transplantation: The CD28 Pathway","volume":"197","author":"Adams","year":"2016","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjhh.2017.02.003","article-title":"Understanding Population-Wide Haplotype Frequencies of Human Leukocyte Antigen (HLA) Alleles in Linkage Disequilibrium Is Important for Hematopoietic Stem Cell Transplantation","volume":"39","author":"Otegbeye","year":"2017","journal-title":"Rev Bras Hematol Hemoter"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-406785","article-title":"Single Nucleotide Polymorphisms and Outcome Risk in Unrelated Mismatched Hematopoietic Stem Cell Transplantation: An Exploration Study","volume":"119","author":"Harkensee","year":"2012","journal-title":"Blood"},{"key":"B26","article-title":"Graft Versus Host Disease. [Updated 2020 Dec 30]","volume-title":"StatPearls","author":"Justiz Vaillant","year":"2021"},{"key":"B27","article-title":"Quantitative Analysis of Chimerism After Allogeneic Peripheral Blood Stem Cell Transplantation","volume":"25","author":"Chen","year":"2002","journal-title":"Chang Gung Med J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.5228","article-title":"Single Nucleotide Polymorphisms Within HLA Region Are Associated With Disease Relapse for Patients With Unrelated Cord Blood Transplantation","volume":"6","author":"Chen","year":"2018","journal-title":"PeerJ"},{"key":"B29","doi-asserted-by":"publisher","first-page":"13731","DOI":"10.1038\/s41598-019-50111-5","article-title":"Association Between Single Nucleotide Polymorphisms Within HLA Region and Disease Relapse for Patients With Hematopoietic Stem Cell Transplantation","volume":"9","author":"Chen","year":"2019","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-0176","article-title":"Genetic Polymorphisms in Cytotoxic T-Lymphocyte Antigen 4 and Cancer: The Dialectical Nature of Subtle Human Immune Dysregulation","volume":"69","author":"Sun","year":"2009","journal-title":"Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1086\/519795","article-title":"PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: Analysis and Visualization of LD and Haplotype Maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s41598-020-79369-w","article-title":"The Adverse Events of Haematopoietic Stem Cell Transplantation Are Associated With Gene Polymorphism Within Human Leukocyte Antigen Region","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep"},{"key":"B34","first-page":"47","article-title":"Costimulatory Molecules in Immune Regulation","volume-title":"Cancer and Infectious Diseases","author":"Manzoor","year":"2013"},{"key":"B35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/82_2017_61","article-title":"CTLA-4, an Essential Immune-Checkpoint for T-Cell Activation","volume":"410","author":"Chikuma","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-0274-0_22","article-title":"Regulation of T Cell Activation by CD28 and CTLA4","volume":"406","author":"Noel","year":"1996","journal-title":"Adv Exp Med Biol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2019.08.010","article-title":"Therapeutic Strategies for the Costimulatory Molecule OX40 in T-Cell-Mediated Immunity","volume":"10","author":"Fu","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"B39","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3934\/medsci.2017.4.395","article-title":"Cytotoxic T-Lymphocyte Associated Antigen-4 (CTLA-4) Polymorphism, Cancer, and Autoimmune Diseases","volume":"4","author":"Tanhapour","year":"2017","journal-title":"AIMS Med Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12929-017-0341-0","article-title":"Cancer Immunotherapy by Targeting Immune Checkpoints: Mechanism of T Cell Dysfunction in Cancer Immunity and New Therapeutic Targets","volume":"24","author":"Tsai","year":"2017","journal-title":"J BioMed Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2009.08.009","article-title":"Regulation of Gene Expression via the Core Promoter and the Basal Transcriptional Machinery","volume":"339","author":"Juven-Gershon","year":"2010","journal-title":"Dev Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2010.1021","article-title":"CTLA4 CT60 Single-Nucleotide Polymorphism is Associated With Slovenian Inflammatory Bowel Disease Patients and Regulates Expression of CTLA4 Isoforms","volume":"29","author":"Repnik","year":"2010","journal-title":"DNA Cell Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04224.x","article-title":"Role of the PD-1 Pathway in the Immune Response","volume":"12","author":"Riella","year":"2012","journal-title":"Am J Transplant"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2394","article-title":"PD-L1 and PD1 Expression in Post-Transplantation Lymphoproliferative Disease (PTLD) of Childhood and Adolescence: An Inter- and Intra-Individual Descriptive Study Covering the Whole Spectrum of PTLD Categories","volume":"8","author":"Schiefer","year":"2019","journal-title":"Cancer Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00109","article-title":"Expression Changes Confirm Genomic Variants Predicted to Result in Allele-Specific, Alternative mRNA Splicing","volume":"11","author":"Mucaki","year":"2020","journal-title":"Front Genet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"7652","DOI":"10.1038\/s41598-017-07967-2","article-title":"Genetic Variation at the CD28 Locus and Its Impact on Expansion of Pro-Inflammatory CD28 Negative T Cells in Healthy Individuals","volume":"7","author":"Liaskou","year":"2017","journal-title":"Sci Rep"},{"key":"B47","first-page":"84","article-title":"Dysregulated Expression of CD28 and CTLA-4 Molecules in Patients With Acute Myeloid Leukemia and Possible Association With Development of Graft Versus Host Disease After Hematopoietic Stem Cell Transplantation","volume":"10","author":"Ramzi","year":"2019","journal-title":"Int J Organ Transplant Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.1900001","article-title":"Central Roles of OX40L-OX40 Interaction in the Induction and Progression of Human T Cell-Driven Acute Graft-Versus-Host Disease","volume":"3","author":"Tripathi","year":"2019","journal-title":"Immunohorizons"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017011502","article-title":"A Novel Predictive Approach for GVHD After Allogeneic SCT Based on Clinical Variables and Cytokine Gene Polymorphisms","volume":"2","author":"Mart\u00ednez-Laperche","year":"2018","journal-title":"Blood Adv"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182708e7c","article-title":"Multiple Single-Nucleotide Polymorphism-Based Risk Model for Clinical Outcomes After Allogeneic Stem-Cell Transplantation, Especially for Acute Graft-Versus-Host Disease","volume":"94","author":"Kim","year":"2012","journal-title":"Transplantation"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2014.20","article-title":"Risk Stratification of Organ-Specific GVHD can be Improved by Single-Nucleotide Polymorphism-Based Risk Models","volume":"49","author":"Kim","year":"2014","journal-title":"Bone Marrow Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.730507\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T05:05:25Z","timestamp":1633323925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.730507\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,4]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2021.730507"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.730507","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,4]]},"article-number":"730507"}}